Markus Hoffmann

Has grant

Professor

University of Lübeck
Country flagGermany

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Markus Hoffmann is a Professor at the University of Lübeck in Germany. His research focuses on inflammatory skin diseases, autoimmune blistering diseases, and therapeutic strategies for inflammatory rheumatic diseases. Recent publications include works on tissue priming in arthritis and the role of spermidine in autophagy and longevity, highlighting his contributions to the understanding of immune regulation and inflammatory pathways.

Recent Grants

Grant: Close

Metabolic and dietary control of inflammatory tissue priming and arthritis

Open Date: 2022-04-01

Close Date: 2025-03-01

Grant: Close

Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation (NeutroCure).

Open Date: 2020-01-01

Close Date: 2025-01-01

Grant: Close

Amplification of NET Formation and Neutrophil Aggregation for the Resolution of Inflammation

Open Date: 2019-07-01

Close Date: 2023-07-01

Grant: Close

Immunometabolic Checkpoints within Synovial Fibroblasts in Rheumatoid Arthritis

Open Date: 2019-04-01

Close Date: 2022-03-01

Grant: Close

The importance of Neutrophil extracellular traps for the resolution of neutrophil-driven inflammation

Open Date: 2015-07-01

Close Date: 2019-06-01

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Clodronate liposomes (Clo-Lip) have been widely used to deplete mononuclear phagocytes (MoPh) to study the function of these cells in vivo. Here, we revisited the effects of Clo-Lip together with genetic models of MoPh deficiency, revealing that Clo-Lip exert their anti-inflammatory effects independent of MoPh. Notably, not only MoPh but also polymorphonuclear neutrophils (PMN) ingested Clo-Lip in vivo, which resulted in their functional arrest. Adoptive transfer of PMN, but not of MoPh, reversed the anti-inflammatory effects of Clo-Lip treatment, indicating that stunning of PMN rather than depletion of MoPh accounts for the anti-inflammatory effects of Clo-Lip in vivo. Our data highlight the need for a critical revision of the current literature on the role of MoPh in inflammation.

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (18)

Simon Sedej

Associate Professor

Medical University of Graz

AUSTRIA
View details

Christoph Becker

-

GERMANY
View details

Claudio De Virgilio

Full Professor

University of Fribourg

SWITZERLAND
View details

Ulrike Steffen

-

GERMANY
View details

Gerhard Krönke

-

GERMANY
View details

Caroline Ospelt

University of Zurich

SWITZERLAND
View details

Mahmoud Abdellatif

Tenure Track Assistant Professor & Group Leader

Medical University of Graz

AUSTRIA
View details

Florence APPARAILLY

INSERM

FRANCE
View details

Evelyn Gaffal

University Hospital Magdeburg

GERMANY
View details

Stephan Blüml

Medical University of Vienna

AUSTRIA
View details

Jacqueline D. Shields

-

UNITED KINGDOM
View details

Raffaele Nicastro

University of Fribourg

SWITZERLAND
View details

Rostyslav Bilyy

-

UKRAINE
View details

Anika Rajput Khokhar

Charité - Universitätsmedizin Berlin

GERMANY
View details

Jason Turner

University of Birmingham

UNITED KINGDOM
View details

Tobias Bäuerle

Professor

University of Erlangen-Nuremberg

GERMANY
View details

Christoph Magnes

Head of Research Group

Joanneum Research

AUSTRIA
View details

Michael Bonelli

Medical University of Vienna

AUSTRIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.